Comparison of Outcomes between Women with De novo Stage IV and Relapsed Breast Cancer

Author:

Kitagawa Dai12,Horiguchi Shin-ichiro3,Yamashita Toshinari1,Kuroi Katsumasa1,Shimizu Kazuo2

Affiliation:

1. Division of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital

2. Department of Endocrine Surgery, Nippon Medical School

3. Division of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Reference23 articles.

1. 1. http://www.jbcs.gr.jp/Member/tourokusyukei.html (as a member-only database of the Japan Breast Cancer society) Accessed 10 October 2013.

2. 2. Harris JR, Morrow M, Bonadonna G: Cancer of the breast. In Cancer. Principles and Practice in Oncology (DeVita VT Jr, Hellman S, Rosenberg SA, eds), 4th edition. 1993; pp 1264-1332, JB Lippincott, Philadelphia.

3. 3. Miller KD, Sledge GW Jr: The role chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am 1999; 13: 415-434.

4. 4. Norton L: Metastatic breast cancer: length and quality of life. N Engl J Med 1991; 325: 1370-1371.

5. 5. Cardoso F, Di LA, Lohrisch C, et al.: Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann Oncol 2002; 13: 197-207.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3